May 21, 2020 / 9:59 PM / 12 days ago

U.S. FDA approves Parkinson's treatment from Sunovion Pharma

May 21 (Reuters) - The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon , for the treatment of “off” episodes in patients with Parkinson’s disease, according to a label published by the agency.

Parkinson's disease is a nervous system disorder in which patients suffer from motor fluctuations which oscillate between "off" times, a state of decreased mobility, and "on" times, or periods when the medication is working and symptoms are controlled. (bit.ly/2Xklr2A) (Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below